Announcements Trials
Browse Landscape

Phase

Phase 2 2

Status

Withdrawn 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 8Genitourinary 5Other hematologic neoplasm 2Lymphoid 2Gynecologic 2Sarcoma 1Myeloid 1CNS 1

Conditions

Lymphoma 3Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Osteoporosis 2Myelodysplastic Syndromes 2Lymphoma, Non-Hodgkin 2Spinal Cord Compression 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Ovarian Neoplasms 1Osteosarcoma 1Osteonecrosis 1Neuroectodermal Tumors, Primitive 1Neuroblastoma 1Multiple Myeloma 1Leukemia, Myeloid, Acute 1Leukemia 1Hodgkin Disease 1Bone Diseases, Metabolic 1

Interventions

Zoledronic Acid 2Vitamin D 2Calcium Carbonate 2Calcium 2Risedronic Acid 1Cholecalciferol 1Calcium Gluconate 1Calcium Citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Osteoporosis × Zoledronic Acid × Lymphoid × Clear all
NCT02632903 2018-08-22

Intravenous Zoledronic Acid for the Treatment of Osteoporosis and Osteonecrosis in Children With Leukemia: A Pilot Study

Children's Hospital of Eastern Ontario

Phase 2 Withdrawn
LymphoidOther hematologic neoplasm

Osteonecrosis, Osteoporosis, Precursor Cell Lymphoblastic Leukemia-Lymphoma

NCT00321932 2017-03-09

Zoledronic Acid in Preventing Osteoporosis in Patients Undergoing Donor Stem Cell Transplant

University of Minnesota

Phase 2 Completed
61 enrolled 16 charts
GynecologicLymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Myelodysplastic Syndromes, Osteoporosis, Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡